Abbott AI Strategy: A Few Measured Bets, Each with a Financial Test
How Abbott uses AI on its own work: a few AI bets with financial tests, a generative AI steering committee, AI education for leaders and an assistant pilot. Updated November 2026.
Medical devices, diagnostics, nutrition products and branded generic medicines
Abbott has no AI strategy document for its own work. This profile is inferred from a July 2026 interview with its CIO and its responsible AI page.
Read the company sourceWhere Abbott Is Going with AI
Abbott is placing a few measured AI bets. Chief Information Officer Sabina Ewing told CIO.com in July 2026: “We’re not going out with a thousand flowers blooming.” Abbott has published no AI strategy for its own work, so this profile is inferred from that interview and company pages.
Every AI investment has to earn its place. Ewing said AI investments face traditional financial measures and need quantifiable outcomes, agreed with senior business leaders. She described matching the type of AI, whether algorithmic, generative or agentic, to the specific problem.
Trust frames the approach. Abbott says its use of AI must be managed, applied and interpreted responsibly and safely. Ewing put it this way: “Trust is earned in drops and lost in buckets.”
The focus has three parts.
- IT operations: new AI capabilities in Abbott’s IT organization, with results Ewing has committed to deliver
- Executive support: an AI-first pilot in which executive assistants use AI as a companion to their work
- Leadership: AI education for top leaders and across the enterprise
What It Takes: A Steering Committee, Leader Education and Financial Tests
A senior committee steers generative AI. Abbott has an executive steering committee on generative AI, and senior leaders take part in deciding where capital goes. Ewing works with HR and finance on AI investment and talent.
Leaders learn first. Ewing led a program that taught Abbott’s top leaders the foundations of AI, and AI education continues across the enterprise in person and online. She said: “If you want to do something sustainable, you can’t do it by yourself.”
AI is a companion in the assistant pilot. Ewing described AI as a companion to the executive assistants’ work, “but not a replacement for it.” Abbott’s stance contrasts with companies that started with a thousand experiments and narrowed later.
Headcount is flat. Abbott had about 115,000 employees at the end of 2025, the same as in 2022. The sources reviewed do not link Abbott’s headcount to AI.
AI fluency, coded against the Lead with AI Fluency Matrix (September 2026 edition):
- Fluency floor: Not published. Abbott runs AI education for leaders and across the enterprise, but it has set no required level for all staff.
- Highest level evidenced: Level 2 (Collaborating), company-claimed. Executive assistants in a pilot use AI as a companion in their daily work. Abbott’s AI products for patients, such as its glucose sensors, are outside the scope of this profile.
- Portfolio design: Abbott funds a small number of AI bets, each tied to a measurable outcome and approved with business leaders.
How Abbott Measures Results
Abbott requires measurable outcomes but publishes few. Ewing said she has “committed two commas of results in IT,” meaning a figure in the millions, but she gave no number. Abbott reports no adoption rates, time savings or cost figures for AI.
Gaps remain. A financial test for every AI bet is the right discipline, and publishing the results is the step from AI adoption to AI value.
Next markers: results from the IT commitments, the outcome of the executive assistant pilot, any wider rollout of AI tools to employees and headcount for 2026.
Change log
- July 2026: Ewing describes Abbott’s measured approach to AI, its steering committee and its education for leaders.
The Bottom Line
- Disclosure: 3 of 4. Abbott answers where it will focus, what it will take and how it measures, in part. It publishes no AI ambition for its own work.
- Few bets, each measured, with a financial test for every AI investment.
- Leaders learn AI first, before tools spread across the company.
- Level 2 is evidenced in an executive assistant pilot.
- The say-do gap is disclosure. Abbott tests every AI bet with numbers but shares none.
- Watch the IT results. The test is whether Abbott reports what its committed results turn out to be.
Revenue, Headcount and Revenue per Employee
What the numbers show: Revenue rose 2% from 2022 to 2025 while headcount was flat at about 115,000, so revenue per employee rose 2%, to about $385,000. Revenue fell in 2023 as COVID-19 test sales dropped, then recovered. These figures do not show that AI caused any change.
Revenue, headcount and revenue per employee, FY2022 to FY2025
- FY2022: $43.65bn revenue, 115,000 employees, $380k per employee
- FY2023: $40.11bn revenue, 114,000 employees, $352k per employee
- FY2024: $41.95bn revenue, 114,000 employees, $368k per employee
- FY2025: $44.33bn revenue, 115,000 employees, $385k per employee
Change, FY2022 to FY2025: revenue up 2%, headcount flat, revenue per employee up 2%.
Notes: Revenue is net sales, as reported. Headcount is approximate, at December 31. Revenue in 2022 included large sales of COVID-19 tests, which fell sharply in 2023.
These figures give context on scale and productivity. They do not show that AI caused any change. Sources: Abbott 10-K filings.
How Abbott Compares with Medical Technology and Health Services Peers
We looked at how Abbott compares with other medical technology and health services companies in the index. Here is how they stack up.
| Company | Disclosure | AI owner | Fluency floor | Governance | AI value reported | Revenue per employee |
|---|---|---|---|---|---|---|
| Abbott | 3 of 4 | CIO; executive steering committee on generative AI | Not published; AI education for leaders | Steering committee; financial test for each AI investment | IT results committed, no figure | $385k |
| CVS Health | 4 of 4 | Chief Experience and Technology Officer | Not published | CEO sets where AI will and will not be used; no published framework | $1B+ savings from technology and AI, AI share not split | $1.34M |
| Danaher | 3 of 4 | CEO links AI to the Danaher Business System | Not published | Through DBS; AI listed as a risk factor | None published | $409k |
| EssilorLuxottica | 2 of 4 | No named AI owner | Not published | Little published | None published | $206k |
| Intuitive Surgical | 2 of 4 | VP of Enterprise Data, Analytics and AI | Not published | AI Governance Committee; published principles | None published | $591k |
| Medtronic | 4 of 4 | IT leads hyperautomation; no single AI leader | Not published; heavy Copilot use | Central oversight of grassroots AI; no published framework | Vendor-reported savings, no total | $383k |
| Thermo Fisher Scientific | 3 of 4 | CIO runs AI platform and governance | Not published; enterprise-wide AI literacy a priority | Responsible AI Framework; AI Technology Council | None published | $356k |
| UnitedHealth Group | 4 of 4 | CEO; Optum Insight CEO leads the AI build | Not published; daily AI use tracked for some Optum staff | AI review board of clinicians, data scientists and ethicists | Results by area and a 2:1 return target, no total | $1.15M |
Disclosure counts how many of the four strategy questions (where it is going, where it will focus, what it will take and how it will know it is working) a company answers in public. Fluency floor is the lowest level of AI fluency a company expects of all its people, on the five levels of the Lead with AI Fluency Matrix: Avoiding (0), Chatting (1), Collaborating (2), Integrating (3) and Transforming (4). The other columns summarize each company’s profile. Revenue per employee is for each company’s latest fiscal year, in US dollars. See all companies in the AI Strategy Index.
Frequently Asked Questions
What is Abbott’s AI strategy for its own work?
Abbott funds a few AI bets, each tied to a measurable outcome. It has published no AI strategy document for its own work.
Who leads AI at Abbott?
Chief Information Officer Sabina Ewing leads Abbott’s internal AI work, with an executive steering committee on generative AI, under Chairman and CEO Robert B. Ford.
How does Abbott train employees on AI?
Abbott runs AI education for its top leaders and across the enterprise, in person and online. It has set no required AI level for all staff.
Is Abbott cutting jobs because of AI?
The sources reviewed show no AI-linked job cuts at Abbott. Headcount was about 115,000 at the end of 2025.
How is this profile put together?
Lead with AI profiles use public sources only, such as annual reports, earnings materials, filings and on-record interviews, dated at the time of writing. AI fluency is coded against the Lead with AI Fluency Matrix, and company figures are marked as company-claimed unless they have been independently verified.
About the AI Strategy Index
The Lead with AI AI Strategy Index profiles how the largest companies in the US and Europe approach AI, starting with the S&P 100 and the STOXX Europe 50. Each profile answers four questions: where the company is going with AI, where it will focus, what it will take and how it will know it is working. AI Pacesetters and notable companies outside the two indexes are profiled for contrast and are not counted. Profiles use public sources only, and AI fluency is coded against the Lead with AI Fluency Matrix.
See all company profiles